ID: ALA3343307

Max Phase: Preclinical

Molecular Formula: C24H38N2O8

Molecular Weight: 482.57

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)N1CCC(C(=O)Nc2ccccc2OCCCO[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O)CC1

Standard InChI:  InChI=1S/C24H38N2O8/c1-15(2)26-10-8-16(9-11-26)23(30)25-17-6-3-4-7-18(17)32-12-5-13-33-22-21(29)20(28)19(14-27)34-24(22)31/h3-4,6-7,15-16,19-22,24,27-29,31H,5,8-14H2,1-2H3,(H,25,30)/t19-,20-,21+,22-,24-/m1/s1

Standard InChI Key:  WHUQXGUMMKOMGZ-WKKMNAASSA-N

Associated Targets(Human)

Coagulation factor X 9693 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Thrombin 1630 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 482.57Molecular Weight (Monoisotopic): 482.2628AlogP: 0.33#Rotatable Bonds: 10
Polar Surface Area: 140.95Molecular Species: BASEHBA: 9HBD: 5
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.29CX Basic pKa: 14.83CX LogP: -0.21CX LogD: -2.11
Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.30Np Likeness Score: -0.21

References

1. Belviso BD, Caliandro R, de Candia M, Zaetta G, Lopopolo G, Incampo F, Colucci M, Altomare CD..  (2014)  How a β-D-glucoside side chain enhances binding affinity to thrombin of inhibitors bearing 2-chlorothiophene as P1 moiety: crystallography, fragment deconstruction study, and evaluation of antithrombotic properties.,  57  (20): [PMID:25268757] [10.1021/jm5010754]

Source